eIF5B increases ASAP1 expression to promote HCC proliferation and invasion
Zhenguang Wang(Beijing Institute of Technology), Weiping Zhou(Shenyang Medical College), Ze‐Ya Pan(Second Military Medical University), Rong Gao(Second Military Medical University), Fangming Gu(Second Military Medical University), Hao Xing(The Graduate Center, CUNY), Wei Gao(Second Military Medical University), Yuan Yang(Central South University), Shuai Li(NYU Langone Health), Hao Ren(Ministry of Education of the People's Republic of China), Jun Han(Second Military Medical University), Hao Zheng(Hunan Normal University), Siyuan Fu(Nanjing University of Posts and Telecommunications), Jingzhu Cao(Second Military Medical University), Hui Liu(Central South University of Forestry and Technology), Jun-sheng Ni(Shanghai Third People's Hospital)
Cited by 32
Related Papers
Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan criteria: A RCT
|Journal of Hepatology|2014|335
Phase I study of CAR-T cells with PD-1 and TCR disruption in mesothelin-positive solid tumors
|Cellular and Molecular Immunology|2021|254
microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity
|British Journal of Cancer|2010|252
Antiviral Therapy Improves Postoperative Survival in Patients With Hepatocellular Carcinoma
|Annals of Surgery|2014|229